SCHEMBL25877992

SCHEMBL25877992

CC(C)(C)c1nc(-c2ccc3cc(-c4ccccc4)ccc3c2)nc(-c2ccc3cc(-c4ccccc4)ccc3c2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.46
ESR2 Q92731 3/20 0.46
CYP11B1 P15538 2/20 0.43
CYP11B2 P19099 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.41
BACE1 P56817 1/20 0.41
MEN1 O00255 2/20 0.40
ALDH1A1 P00352 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
KDM4E B2RXH2 1/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP17A1 P05093 1/20 0.39
CYP19A1 P11511 1/20 0.39
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25878008 0.93 MEN1 (0.47) ESR1ESR2CYP11B1CYP11B2L3MBTL1
SCHEMBL23473684 0.92 MEN1 (0.49) ESR1ESR2CYP11B1CYP11B2L3MBTL1
SCHEMBL25877993 0.91 L3MBTL1 (0.41) ESR1ESR2CYP11B1CYP11B2L3MBTL1
SCHEMBL22249759 0.90 MEN1 (0.44) ESR1ESR2CYP11B1CYP11B2L3MBTL1
SCHEMBL22249621 0.90 L3MBTL1 (0.46) L3MBTL1MEN1ALDH1A1KMT2AMAPT
SCHEMBL25762542 0.90 L3MBTL1 (0.46) L3MBTL1MEN1ALDH1A1KMT2AMAPT
SCHEMBL25878011 0.90 L3MBTL1 (0.46) L3MBTL1MEN1ALDH1A1KMT2AMAPT
SCHEMBL19862808 0.89 GSTP1 (0.41) ESR1ESR2CYP11B1CYP11B2MEN1
SCHEMBL23473555 0.89 L3MBTL1 (0.44) L3MBTL1MEN1ALDH1A1KMT2AMAPT
SCHEMBL24622649 0.88 L3MBTL1 (0.47) L3MBTL1MEN1ALDH1A1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192669-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 US disclosed
US-20230192669-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192669-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS ACHE, OR51E2, L1CAM ESR1 511/4885ESR2 816/4885CYP11B1 3257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.